Hsp70 is phosphorylated in a conserved response to DNA damage and contributes to cell cycle control

This study reveals that DNA damage triggers the conserved phosphorylation of Hsp70 at threonine 495, which locks the chaperone in an open conformation to regulate G1/S cell cycle progression and delay division until repair is complete.

The Gist

The Big Picture: A Cellular "Brake" System

Imagine your body's cells are like busy, high-speed factories. Inside these factories, there are millions of workers (proteins) constantly building, fixing, and moving things. To keep everything running smoothly, the factory needs a supervisor who can pause the assembly line if something goes wrong.

That supervisor is a protein called Hsp70. It's a "molecular chaperone," which means its job is to help other proteins fold into the right shape and get them to where they need to go.

This paper discovers a fascinating new way the cell uses Hsp70 to stop the factory from running when the DNA (the factory's master blueprint) gets damaged. It turns out that Hsp70 has a specific "off switch" or "brake" that gets flipped on when things get messy, but only after the cell has tried to fix the mess and failed.

The Story Unfolds

1. The Accidental Discovery (The Thief's Clue)

Scientists first noticed this specific "switch" on Hsp70 because of a bacterial thief. A bacterium called Legionella pneumophila (which causes Legionnaires' disease) has a weapon: a tiny enzyme that steals into human cells and flips this switch on Hsp70. By doing this, the bacteria shuts down the cell's protein factory so the bacteria can take over.

The researchers asked a simple question: "If a bacteria needs to flip this switch to take over the cell, maybe the cell uses this same switch for something important on its own?"

2. The Trigger: When the Blueprint Gets Stuck

The researchers found that the cell flips this switch (by adding a phosphate tag to a specific spot on Hsp70, called T495) when the DNA gets damaged.

• The Scenario: Imagine the DNA is a long instruction manual. Sometimes, chemicals (like MMS or arsenic) scribble over the pages, creating "typos."
• The Repair Crew: The cell has a repair crew called Base Excision Repair (BER). They come in, cut out the typo, and try to paste in the correct letter.
• The Problem: If there are too many typos, the repair crew gets overwhelmed. They leave "half-finished" jobs (broken strands of DNA) lying around.
• The Alarm: The cell realizes, "Whoa, we have too many half-finished repairs!" This triggers the Hsp70 switch.

3. The Timing: Waiting for the Right Moment

Here is the most surprising part of the discovery. The switch doesn't flip immediately when the damage happens.

• The Analogy: Imagine a construction site. If a wall falls down, you don't stop the whole city immediately. You let the repair crew try to fix it. But, if the repair crew is still working when the "night shift" (Cell Division/Mitosis) is about to start, that's a disaster. You can't start building a new building on top of a half-repaired foundation.
• The Finding: The cell waits until it tries to divide (enter Mitosis). If the DNA is still messy, the Hsp70 switch flips after the cell has already started the process of dividing. It acts as a "emergency brake" to stop the cell from finishing the division until the DNA is safe.

4. How the Switch Works (The "Pseudo-Open" State)

What happens when the switch flips?

• Normal Hsp70: It's like a hand that opens and closes. It grabs a protein, holds it, and then lets go.
• Phosphorylated Hsp70 (The Switched-On Version): The researchers found that when the switch is flipped, the "hand" gets stuck in a weird position. It looks like it's open (ready to grab), but it's actually locked in a way that slows down its ability to let go.
• The Result: It's like a worker who is holding onto a tool but can't put it down. This change in behavior signals the cell cycle to stop. It tells the cell: "Don't move to the next phase (S-phase) yet! We aren't ready!"

5. Proof in Yeast (The Tiny Test Subjects)

To prove this wasn't just a fluke in human cells, they tested it in yeast (tiny single-celled fungi).

• They created yeast with a "broken" switch (one that couldn't be turned on) and yeast with a "stuck" switch (one that was always on).
• The Result: Both types of yeast got into trouble when their DNA was damaged. The "stuck" switch yeast couldn't start building new cells, and the "broken" switch yeast started building new cells before they were ready, leading to errors.
• Conclusion: This mechanism is ancient and conserved. It's a fundamental safety rule for life, used by both humans and yeast.

The Takeaway

This paper reveals a brilliant piece of biological engineering:

1. Hsp70 is not just a helper; it's a gatekeeper for the cell cycle.
2. When DNA repair gets overwhelmed, the cell adds a phosphate tag to Hsp70.
3. This tag changes Hsp70's shape, acting as a molecular brake.
4. This brake stops the cell from dividing until the DNA damage is fixed, preventing the creation of mutated, cancerous cells.

The "Pathogen Lesson": The most exciting part is that we only found this because a bacteria tried to hack it. It's like finding a hidden safety feature on a car only because a thief tried to hotwire it. Nature often uses the same tools for defense and offense, and by studying the "thief," we learned how the "guard" actually works.

Technical Summary

1. Problem Statement

Hsp70s are essential molecular chaperones regulated by co-chaperones and post-translational modifications (PTMs). While previous research established that the bacterial pathogen Legionella pneumophila phosphorylates human Hsp70 (Hsc70) at threonine 495 (T495) via the kinase LegK4 to inhibit protein synthesis, the endogenous physiological role of this phosphorylation site in human cells remained unknown. Similarly, in yeast (S. cerevisiae), the homologous residue (Ssa1-T492) was known to be phosphorylated during DNA damage and mitotic exit, but the functional consequences of this modification on chaperone activity and cell cycle progression were not characterized. The study aimed to determine if T495 phosphorylation is an endogenous regulatory mechanism in human cells, identify the upstream signaling pathways involved, and elucidate the biochemical and cellular consequences of this modification.

2. Methodology

The researchers employed a multidisciplinary approach combining biochemistry, cell biology, and yeast genetics:

• Biochemical Characterization:
  • Mutagenesis: Generated a phosphomimetic mutant (T495E) and a phosphonull mutant (T495A) of human Hsc70 to mimic phosphorylated and unphosphorylated states, respectively.
  • Enzymatic Assays: Measured ATPase activity using a malachite green assay with the co-chaperone DnaJA2.
  • Binding Assays: Used fluorescence polarization (FP) to assess ATP binding and an ELISA to test substrate (tau protein) binding.
  • Conformational Analysis: Performed partial proteolysis (trypsin digestion) to distinguish between "open" (ATP-bound) and "closed" (ADP-bound) conformations.
• Cellular Studies (Human):
  • DNA Damage Induction: Treated HEK293T and HeLa cells with various genotoxic agents (MMS, arsenite, bleomycin, etc.) to induce specific DNA damage pathways.
  • Pathway Perturbation: Used siRNA knockdowns and pharmacological inhibitors to target DNA damage response (DDR) kinases (ATM, DNA-PKcs, ATR, Chk2, CK1) and Base Excision Repair (BER) enzymes (APE1, MPG, Polb).
  • Cell Cycle Analysis: Utilized flow cytometry, Western blotting for cell cycle markers (pH3, CDT1, Cyclins), and nuclear/cytoplasmic fractionation to determine the timing of phosphorylation relative to cell cycle phases.
• Yeast Genetics (S. cerevisiae):
  • Strain Construction: Created endogenous point mutations (T492E and T492A) in the SSA1 gene and deleted the redundant SSA2 gene to isolate phenotypic effects.
  • Phenotypic Assays: Conducted growth curves, spot assays on MMS-containing media, and flow cytometry-based cell cycle profiling to assess G1/S transition and recovery from DNA damage.

3. Key Contributions

• Discovery of Endogenous Regulation: Demonstrated that Hsp70 phosphorylation at T495 is not merely a pathogen hijacking mechanism but a conserved, endogenous response to DNA damage in both human and yeast cells.
• Mechanistic Insight into Chaperone Conformation: Revealed that phosphorylation (or phosphomimicry) locks Hsp70 in an "open-like" conformation that retains substrate binding capability but allosterically impairs ATP hydrolysis.
• Linking BER to Cell Cycle Control: Established a specific signaling axis where Base Excision Repair (BER) intermediates trigger a kinase cascade (involving ATM, DNA-PKcs, Chk2, and CK1) that phosphorylates Hsp70, acting as a molecular brake on the G1/S transition.
• Pathogen-to-Host Insight: Validated the concept that studying pathogen effectors can uncover fundamental, conserved host regulatory mechanisms.

4. Key Results

A. Biochemical Properties of the Phosphomimetic Mutant (T495E)

• ATPase Activity: The T495E mutant exhibited significantly reduced J-protein-stimulated ATPase activity compared to wild-type (WT) Hsc70, despite having normal ATP binding affinity.
• Conformation: Partial proteolysis assays showed that T495E adopts an "ATP-like" (open) conformation regardless of the nucleotide state, suggesting the mutation locks the protein in an open state.
• Substrate Engagement: Unlike typical open-state Hsp70s, T495E retained the ability to bind client proteins (tau), indicating a "pseudo-open" state that allows substrate engagement but prevents the conformational cycling required for efficient chaperone function.

B. Induction by DNA Damage and BER Pathway

• Specificity: Phosphorylation of Hsp70 (pHsp70) was induced by MMS (alkylating agent) and sodium arsenite (oxidative stress), both of which generate substrates for Base Excision Repair (BER). It was not observed with agents causing double-strand breaks (bleomycin) or replication stress (hydroxyurea) alone.
• BER Dependence: pHsp70 levels increased when the BER initiator MPG was overexpressed but were abolished when the BER endonuclease APE1 was inhibited or when AP sites were blocked by methoxyamine. This indicates that BER intermediates (specifically single-strand breaks generated by APE1) trigger the response.
• Kinase Cascade: Phosphorylation required the activity of DDR kinases ATM, DNA-PKcs, Chk2, and CK1. However, the phosphorylation event occurred with a significant time lag (hours) compared to the immediate activation of these kinases, suggesting a secondary signaling event or a requirement for cell cycle progression.

C. Cell Cycle Timing and Mitotic Entry

• Mitotic Requirement: Surprisingly, Hsp70 phosphorylation did not occur if cells were blocked from entering mitosis (using CDK1 inhibitor Ro3306). Phosphorylation only occurred after cells passed through M phase, even in the presence of DNA damage.
• Persistence: Once phosphorylated, the modification persisted after mitotic exit and nuclear envelope reformation, suggesting it acts as a checkpoint signal preventing immediate re-entry into S phase.

D. Yeast Genetic Analysis

• Growth Defects: In yeast lacking the compensatory SSA2, both phosphomimetic (T492E) and phosphonull (T492A) mutants showed growth defects, indicating that dynamic, reversible phosphorylation is essential.
• Cell Cycle Arrest: The T492E mutant caused a strong G1 arrest (1N DNA content) and delayed S-phase progression after MMS treatment. Conversely, T492A mutants failed to maintain proper G1 arrest, leading to dysregulated S-phase entry.
• Dominant Effect: The T492E mutant exhibited a dominant-like phenotype, causing growth defects even in the presence of wild-type SSA2, likely due to the "locked" conformation interfering with normal chaperone cycling.

5. Significance

This study uncovers a conserved "phospho-switch" on Hsp70 that integrates DNA damage sensing with cell cycle control.

• Mechanism of Action: The phosphorylation at T495/T492 acts as a reversible molecular brake. By locking Hsp70 in a conformation that binds clients but cannot cycle efficiently, the cell delays the G1/S transition to allow time for DNA repair, preventing the replication of damaged genomes.
• Therapeutic Implications: Understanding this regulatory node could inform cancer therapies, as Hsp70 is often overexpressed in tumors to promote survival. Modulating this phosphorylation site could sensitize cancer cells to DNA-damaging agents.
• Paradigm Shift: The work highlights how pathogen-derived insights (Legionella LegK4 kinase) can reveal fundamental host biology, demonstrating that pathogens often target highly conserved, critical regulatory nodes.

In summary, the paper defines a novel checkpoint mechanism where BER-induced DNA damage triggers a kinase cascade that phosphorylates Hsp70, altering its conformation to delay cell cycle progression and safeguard genome integrity.